News

We are delighted to share exciting news from the Karina Yaniv Lab.

Prof. Karina Yaniv has been appointed Scientific Director of the Helmholtz Institute for Translational AngioCardioScience (HI-TAC) at Heidelberg University. Beginning in April 2026, she will lead the institute’s scientific vision, guiding its mission to bridge fundamental biological research with clinical applications in cardiovascular disease.

HI-TAC is dedicated to advancing our understanding of vascular biology and translating these insights into meaningful therapeutic strategies. This new role reflects Prof. Yaniv’s longstanding commitment to curiosity-driven research, innovative thinking, and the translation of scientific discoveries into real-world impact.

Within the lab, we witness firsthand the energy, rigor, and creativity she brings to both science and mentorship. Her leadership has been instrumental not only in advancing research in vascular and lymphatic biology, but also in fostering a collaborative and forward-thinking scientific community.

This new chapter will extend that impact even further—expanding efforts to uncover the mechanisms underlying blood and lymphatic vessel development and function, while contributing to global initiatives aimed at addressing cardiovascular disease at its core.

We are incredibly proud of this achievement and look forward to the continued growth and impact of this work.

Congratulations, Karina, on this well-deserved appointment.

We are proud to share that Noya Levy, a member of the Yaniv Lab, has been awarded the prestigious Michigan–Israel Partnership for Research and Education (MIPRE) Exchange Program.

This competitive program supports collaborative research initiatives between leading institutions in Israel and the United States, fostering scientific exchange and strengthening international partnerships.

As part of this award, Noya will collaborate with the Shikanov Lab at the University of Michigan on a research project focused on characterizing the development and function of lymphatic vessels in the ovary. This work aims to advance our understanding of the role of the lymphatic system in reproductive biology, with potential implications for both basic science and future clinical research.

Noya’s achievement reflects her dedication, scientific curiosity, and the high standard of research within the lab. The opportunity to engage in international collaboration will not only contribute to the success of this project but also bring valuable perspectives and insights back to our research community.

We warmly congratulate Noya on this well-deserved recognition and look forward to following the progress of this exciting collaboration.

The Karina Yaniv Lab is proud to announce the successful defense of Gal Perlmoter's PhD thesis.

Gal’s dissertation, “The Role of the Lymphatic System in Cardiac Growth, Repair and Regeneration,” represents years of curiosity-driven research, scientific rigor, and unwavering dedication. Her work explores how the lymphatic system contributes to heart development and recovery, advancing our understanding of fundamental mechanisms that may one day inform regenerative and cardiovascular medicine.

Throughout her doctoral journey, Gal demonstrated remarkable commitment, resilience, and intellectual depth. It has been a privilege to witness her growth as a scientist and to see her research culminate in such a meaningful and impressive body of work.

This milestone reflects not only Gal’s hard work and talent, but also the spirit of collaboration, mentorship, and trust that shapes our lab community

Congratulations to Prof. Karina Yaniv of the Immunology and Regenerative Biology Department for being awarded the European Research Council (ERC) Synergy Grant for 2024.